THE COST-EFFECTIVENESS OF TAVI IN INOPERABLE AND HIGH RISK PATIENTS IN FRANCE

被引:0
|
作者
Goodall, G. [1 ]
Zemanova, B. [2 ]
Candolfi, P. [1 ]
Sohlberg, A. [1 ]
机构
[1] Edwards Lifesci, Nyon, Switzerland
[2] Edwards Lifesci, Irvine, CA USA
关键词
D O I
10.1016/j.jval.2017.08.1080
中图分类号
F [经济];
学科分类号
02 ;
摘要
PMD96
引用
收藏
页码:A589 / A589
页数:1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF ICOSAPENT ETHYL FOR PATIENTS AT HIGH CARDIOVASCULAR RISK WITH ELEVATED TRIGLYCERIDES IN GREECE
    Stratopoulos, A.
    Kougioumtzoglou, I
    Mortaki, K.
    Rigopoulos, P.
    Jakouloff, D.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S51 - S51
  • [42] Cost-Effectiveness of Skin Surveillance Through a Specialized Clinic for Patients at High Risk of Melanoma
    Watts, Caroline G.
    Cust, Anne E.
    Menzies, Scott W.
    Mann, Graham J.
    Morton, Rachael L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (01) : 63 - +
  • [43] Cost-effectiveness of pharmacist care for managing patients at high risk for cardiovascular disease in Canada
    Al Hamarneh, Y. N.
    Johnston, K.
    Marra, C.
    Tsuyuki, R.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 297 - 298
  • [44] A pragmatic, randomised, controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer
    Shenfine, J
    McNamee, P
    Steen, N
    Glendinning, S
    Bond, J
    Griffin, SM
    [J]. BRITISH JOURNAL OF SURGERY, 2004, 91 : 101 - 102
  • [45] Cost and cost-effectiveness of childhood vaccination against rotavirus in France
    Melliez, H.
    Levybruhl, D.
    Boelle, P. Y.
    Dervaux, B.
    Baron, S.
    Yazdanpanah, Y.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2007, 17 : 208 - 208
  • [46] A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer
    Shenfine, J
    McNamee, P
    Steen, N
    Bond, J
    Griffin, SM
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2005, 9 (05) : 1 - +
  • [47] Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation
    Orlando, R.
    Pennant, M.
    Rooney, S.
    Khogali, S.
    Bayliss, S.
    Hassan, A.
    Moore, D.
    Barton, P.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2013, 17 (33) : 1 - +
  • [48] Cost and cost-effectiveness of childhood vaccination against rotavirus in France
    Melliez, H.
    Levybruhl, D.
    Boelle, P. Y.
    Dervaux, B.
    Baron, S.
    Yazdanpanah, Y.
    [J]. VACCINE, 2008, 26 (05) : 706 - 715
  • [49] Cost-effectiveness of management strategies for patients with recurrent ovarian cancer and inoperable malignant bowel obstruction
    Peters, Pamela N.
    Moyett, Julia M.
    Davidson, Brittany A.
    Cantrell, Sarah
    Bliss, Sara E.
    Havrilesky, Laura J.
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 167 (03) : 523 - 531
  • [50] Cost-effectiveness of management strategies for patients with recurrent ovarian cancer and inoperable malignant bowel obstruction
    Peters, Pamela
    Bliss, Sara
    Davidson, Brittany
    Havrilesky, Laura
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S54 - S54